A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma
Hux, Margaret, Zou, Denise, Ma, Esprit, Sajosi, Peter, Engstrom, Andreas, Ross, Selby, Benson, Eugene, Briggs, Andrew, Bonthapally, Vijayveer
Published in Journal of health economics and outcomes research (Online) (26.10.2016)
Published in Journal of health economics and outcomes research (Online) (26.10.2016)
Get full text
Journal Article
Real-world evidence use in assessments of cancer drugs by NICE
Bullement, Ash, Podkonjak, Tanja, Robinson, Mark J., Benson, Eugene, Selby, Ross, Hatswell, Anthony J., Shields, Gemma E.
Published in International journal of technology assessment in health care (01.08.2020)
Published in International journal of technology assessment in health care (01.08.2020)
Get full text
Journal Article
Cost-effectiveness of vedolizumab compared with infliximab, adalimumab, and golimumab in patients with ulcerative colitis in the United Kingdom
Wilson, Michele R., Bergman, Annika, Chevrou-Severac, Helene, Selby, Ross, Smyth, Michael, Kerrigan, Matthew C.
Published in The European journal of health economics (01.03.2018)
Published in The European journal of health economics (01.03.2018)
Get full text
Journal Article
Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
Kay, Stephen, Strickson, Amanda, Puelles, Jorge, Selby, Ross, Benson, Eugene, Tolley, Keith
Published in Diabetes therapy (01.04.2017)
Published in Diabetes therapy (01.04.2017)
Get full text
Journal Article
Cost-effectiveness of brentuximab vedotin in relapsed or refractory systemic anaplastic large cell lymphoma
Hux, Margaret, Zou, Denise, Ma, Esprit, Sajosi, Peter, Engstrom, Andreas, Selby, Ross, Benson, Eugene, Teasell, Jeremy, Richhariya, Akshara, Briggs, Andrew, Bonthapally, Vijayveer
Published in Journal of clinical oncology (01.03.2016)
Published in Journal of clinical oncology (01.03.2016)
Get full text
Journal Article
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant: A cost-effectiveness analysis updated with 5-year follow-up data from the pivotal trial
Parker, Christopher, Kay, Gemma, Ma, Esprit, Woods, Beth, Eaton, James, Sajosi, Peter, Engstrom, Andreas, Selby, Ross, Benson, Eugene, Teasell, Jeremy, Richhariya, Akshara, Briggs, Andrew, Bonthapally, Vijayveer
Published in Journal of clinical oncology (01.03.2016)
Published in Journal of clinical oncology (01.03.2016)
Get full text
Journal Article
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous stem cell transplant: a cost-effectiveness analysis in Scotland
Parker, Christopher, Woods, Beth, Eaton, James, Ma, Esprit, Selby, Ross, Benson, Eugene, Engstrom, Andreas, Sajosi, Peter, Briggs, Andrew, Bonthapally, Vijayveer
Published in Journal of medical economics (02.01.2017)
Published in Journal of medical economics (02.01.2017)
Get more information
Journal Article
Cost-effectiveness of vedolizumab compared with conventional therapy for ulcerative colitis patients in the UK
Wilson, Michele R, Azzabi Zouraq, Ismail, Chevrou-Severac, Helene, Selby, Ross, Kerrigan, Matthew C
Published in ClinicoEconomics and outcomes research (01.01.2017)
Published in ClinicoEconomics and outcomes research (01.01.2017)
Get full text
Journal Article